探花精选

Ivan Nalvarte

Ivan Nalvarte

Principal Researcher | Docent
Visiting address: BioClinicum J9:20, Visionsgatan 4, 17165 Solna
Postal address: H1 Neurobiologi, v氓rdvetenskap och samh盲lle, H1 Neurogeriatrik Nalvarte, 171 77 Stockholm
Part of:

About me

  • Associate professor (Docent, Senior researcher). 


    I am a principal investigator and group leader at the Division of Neurogeriatrics at Department of Neurobiology, Care Sciences and Society, 探花精选, Sweden.

    Lab webpage - under construction!

Research

  • My background is in neuroendocrinology and my research focuses on the effects of sex hormone signaling on healthy brain aging. A major research topic of mine is how aberrant sex hormone signaling during endocrine sensitive life stages can modulate risk of depressive and neurodegenerative conditions. To this end, I am part of a network of specialists that employ multidisciplinary approaches, combining human epidemiological data with innovative experimental modeling and large-scale data integration to spearhead this research area.

Teaching

  • 2019-2023: Course leader: Biomedicine Master program thesis work and
    examination, 探花精选
    2018- : Target Organ Toxicology, Nuclear receptor signalling and EDCs,  探花精选
    2016- : Tutor in 鈥淪ex hormones and ESC differentiation鈥, Post-graduate
    course in Human Embryonic Stem Cells, 2212, 探花精选
    2015-: Co-organizer and Responsible for the course Functional Genomics,
    Biomedicine Bachelor programme, Karolinska Institute, Stockholm, Sweden
    2014-2017: Applied Science Communication (ACB2), Biomedicine Master
    programme, Karolinska Institute, Stockholm, Sweden
    2013- : Applied Science Communication (ACB4), Biomedicine Master programme,
    Karolinska Institute, Stockholm, Sweden
    2014- : Tutor in 鈥淧roteomic techniques and applications鈥, Biomedicine
    Bachelor programme, Karolinska Institute, Stockholm, Sweden
    03/2012: Tutor in WiMo 2012 Wissenschaftsmonat f眉r Medizinstudierende,
    theory, University of Basel, basel, Switzerland
    09-10/2011: Tutor in Introduction to Biology, theory. University of Basel,
    Basel, Switzerland
    2008-2009: Tutor in 鈥淧roteomic techniques and applications鈥, Molecular
    Nutrition undergraduate programme, Stockholm University, Stockholm, Sweden
    2008-2009: Responsible for the Theoretical and practical teaching in
    proteomics for researchers. Department of Biosciences and Nutrition,
    Karolinska Institute, Huddinge, Sweden
    2007-2009: Molecular biology. Theory and practice. Co-responsible for the
    course. Biomedicine undergraduate programme, Karolinska Institute, Stockholm,
    Sweden
    2002-2006: Teaching assistance at undergraduate courses in Molecular
    immunology, Molecular Biology, Cell Biology, and General Chemistry at
    S枚dert枚rns h枚gskola and Karolinska Institute, Stockholm, Sweden.

Articles

  • Journal article: ENVIRONMENTAL RESEARCH. 2025;285(Pt 2):122435
    Lu SSM; Ekbaeck E; Sommar JN; Anderson S; Olstrup H; Harlid S; Gustafsson S; Mattisson K; Stockfelt L; Rein T; Nalvarte I; Rueegg J; Oudin A
  • Article: BIOLOGY OF SEX DIFFERENCES. 2025;16(1):29
    Demetriou A; Lindqvist B; Ali HG; Shamekh MM; Varshney M; Inzunza J; Maioli S; Nilsson P; Nalvarte I
  • Journal article: STEM CELL RESEARCH. 2025;82:103628
    Petru拧kevi膷i奴t臈 A; 艩imuli奴nait臈 U; Polanco CM; Rojas B; Kuras S; Valatkait臈-Rak拧tien臈 B; Norvilas R; Vijaya AK; Mu帽oz P; Neni拧kyt臈 U; Jakubauskas A; Burokas A; Nalvarte I; Inzunza J; Naumovas D; Sto拧kus M; Gri拧kevi膷ius L; Baltriukien臈 D; Arias J
  • Article: STEM CELL RESEARCH. 2025;82:103628
    Petruskeviciute A; Simuliunaite U; Polanco CM; Rojas B; Kuras S; Valatkaite-Rakstiene B; Norvilas R; Vijaya AK; Munoz P; Neniskyte U; Jakubauskas A; Burokas A; Nalvarte I; Inzunza J; Naumovas D; Stoskus M; Griskevicius L; Baltriukiene D; Arias J
  • Article: CELLS. 2024;13(21):1811
    Jiang Y; Palomares AR; Munoz P; Nalvarte I; Acharya G; Inzunza J; Varshney M; Rodriguez-Wallberg KA
  • Article: F AND S SCIENCE. 2024;5(4):306-317
    Tohonen V; Antonson P; Boggavarapu NR; Ali H; Motaholi LA; Gustafsson J-A; Varshney M; Rodriguez-Wallberg KA; Katayama S; Nalvarte I; Inzunza J
  • Article: SCIENCE ADVANCES. 2024;10(4):eadj1354
    Latorre-Leal M; Rodriguez-Rodriguez P; Franchini L; Nikolidakis O; Daniilidou M; Delac L; Varshney MK; Arroyo-Garcia LE; Eroli F; Winblad B; Blennow K; Zetterberg H; Kivipelto M; Pacciarini M; Wang Y; Griffiths WJ; Bjoerkhem I; Matton A; Nalvarte I; Merino-Serrais P; Cedazo-Minguez A; Maioli S
  • Journal article: FERTILITY AND STERILITY. 2023;120(4):e194
    Jiang Y; Varshney M; Palomares AR; Inzunza J; Acharya G; Nalvarte I; Rodriguez-Wallberg KA
  • Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(15):12461
    Song X; Wu W; Dai Y; Warner M; Nalvarte I; Antonson P; Varshney M; Gustafsson J-A
  • Journal article: RECEPTORS. 2023;2(1):116-126
    Nalvarte I; Antonson P
  • Article: CELL DEATH & DISEASE. 2023;14(2):129
    Raccosta L; Marinozzi M; Costantini S; Maggioni D; Ferreira LM; Corna G; Zordan P; Sorice A; Farinello D; Bianchessi S; Riba M; Lazarevic D; Provero P; Mack M; Bondanza A; Nalvarte I; Gustafsson J-A; Ranzani V; De Sanctis F; Ugel S; Baron S; Lobaccaro J-MA; Pontini L; Pacciarini M; Traversari C; Pagani M; Bronte V; Sitia G; Antonson P; Brendolan A; Budillon A; Russo V
  • Article: MOLECULAR PSYCHIATRY. 2021;26(11):6380-6393
    Li X; Zhong H; Wang Z; Xiao R; Antonson P; Liu T; Wu C; Zou J; Wang L; Nalvarte I; Xu H; Warner M; Gustafsson J-A; Fan X
  • Article: FRONTIERS IN ENDOCRINOLOGY. 2021;12:721813
    Brundin PMA; Landgren B-M; Fjallstrom P; Shamekh MMM; Gustafsson J-A; Johansson AFF; Nalvarte I
  • Article: STEM CELLS TRANSLATIONAL MEDICINE. 2021;10(7):987-995
    Arias J; Yu J; Varshney M; Inzunza J; Nalvarte I
  • Article: NEUROTOXICITY RESEARCH. 2021;39(2):182-190
    Valdes R; Armijo A; Munoz P; Hultenby K; Hagg A; Inzunza J; Nalvarte I; Varshney M; Mannervik B; Segura-Aguilar J
  • Article: STEM CELL RESEARCH. 2021;51:102193
    Inzunza J; Arias-Fuenzalida J; Segura-Aguilar J; Nalvarte I; Varshney M
  • Article: NEUROENDOCRINOLOGY. 2021;111(1-2):27-44
    Varshney MK; Yu NY-L; Katayama S; Li X; Liu T; Wu W-F; Tohonen V; Krjutskov K; Kere J; Fan X; Inzunza J; Gustafsson J-A; Nalvarte I
  • Article: HELIYON. 2020;6(11):e05535
    Brundin PMA; Landgren B-M; Fjallstrom P; Johansson AF; Nalvarte I
  • Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2020;529(2):231-237
    Antonson P; Apolinario LM; Shamekh MM; Humire P; Poutanen M; Ohlsson C; Nalvarte I; Gustafsson J-A
  • Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(9):4902-4909
    Warner M; Wu W-F; Montanholi L; Nalvarte I; Antonson P; Gustafsson J-A
  • Show more

All other publications

  • Preprint: MEDRXIV. 2025
    Naumovas D; Rojas-Araya B; Polanco CM; Andrade V; 膶ekauskien臈 R; Valatkait臈-Rak拧tien臈 B; Laurinaityt臈 I; Jakubauskas A; Sto拧kus M; Gri拧kevi膷ius L; Nalvarte I; Inzunza J; Baltriukien臈 D; Arias J
  • Preprint: BIORXIV. 2025
    Wang Y; Lorentz J; Mohammadi E; Yilmaz DE; Sgouras T; Guo Y; Pizzirusso G; Demetriou A; Nalvarte I; Schultzberg M; Li X
  • Editorial comment: FRONTIERS IN ENDOCRINOLOGY. 2024;15:1472908
    Le Menuet D; Charalampopoulos IN; Cunningham RL; Kalafatakis K; Nalvarte I
  • Preprint: BIORXIV. 2024;BIORXIV
    Demetriou A; Lindqvist B; Ali HG; Shamekh MM; Maioli S; Inzunza J; Varshney M; Nilsson P; Nalvarte I
  • Review: ENDOCRINOLOGY. 2023;164(6):bqad063
    Birgersson M; Indukuri R; Antonson P; Nalvarte I; Archer A; Williams C
  • Review: NEURAL REGENERATION RESEARCH. 2022;17(9):1861-1866
    Segura-Aguilar J; Mannervik B; Inzunza J; Varshney M; Nalvarte I; Munoz P
  • Review: ANTIOXIDANTS. 2022;11(2):296
    Segura-Aguilar J; Munoz P; Inzunza J; Varshney M; Nalvarte I; Mannervik B
  • Review: ESSAYS IN BIOCHEMISTRY. 2021;65(6):913-925
    Maioli S; Leander K; Nilsson P; Nalvarte I
  • Corrigendum: HELIYON. 2021;7(3):e06568
    Brundin PMA; Landgren B-M; Fjallstrom P; Johansson AF; Nalvarte I
  • Review: HORMONES AND AGING. 2021;116:313-326
    Nalvarte I; Varshney M; Inzunza J; Gustafsson J-A
  • Editorial comment: BRAIN SCIENCES. 2020;10(2):E103-103
    Nalvarte I
  • Meeting abstract: TOXICOLOGY LETTERS. 2018;295:S109-S110
    Lupu D; Varshney M; Nalvarte I; Insunza J; Loghin F; Ruegg J
  • Book chapter: EPIGENETICS AND ASSISTED REPRODUCTION. 2018;p. 99-114
    Nalvarte I; R眉egg J; Guerrero-Bosagna C
  • Review: BRAIN SCIENCES. 2017;7(3):E24-24
    Varshney M; Nalvarte I
  • Corrigendum: SCIENCE SIGNALING. 2014;7(333)
    MacDonald G; Nalvarte I; Smirnova T; Vecchi M; Aceto N; Doelemeyer A; Frei A; Lienhard S; Wyckoff J; Hess D; Seebacher J; Keusch JJ; Gut H; Salaun D; Mazzarol G; Disalvatore D; Bentires-Alj M; Di Fiore PP; Badache A; Hynes NE
  • Meeting abstract: CANCER RESEARCH. 2012;72:pd01-06-pd01-06
    Hynes NE; Gattelli A; Nalvarte I; Roloff T
  • Book chapter: HORMONE-DISRUPTIVE CHEMICAL CONTAMINANTS IN FOOD. 2011;p. 44-69
    Damdimopoulou P; Weis S; Nalvarte I; R眉egg J
  • Meeting abstract: TOXICOLOGY LETTERS. 2006;164:S299
    Nalvarte I; Spyrou G
  • Doctoral thesis: 2006
    Nalvarte I
  • Conference publication: FREE RADICAL BIOLOGY AND MEDICINE. 2004;36:S73
    Nalvarte I; Damdimopoulos AE; Spyrou G
  • Show more

Grants

  • Swedish Research Council
    1 December 2024 - 30 November 2027
    Experimental research on Alzheimer麓s disease (AD) relies heavily on mouse models, but these models poorly mimic human AD, leading to over 99% AD drugs failures in human trials. Consequently, there is an urgent need for more human-relevant experimental models of AD. However, the use of alternative human cell models is constrained due to the complex 3D multi-cellular nature of AD pathology, including an inflammatory component. In addition, their superiority over animal models remains uncertain, combined with insufficient validation regarding their relevance to human disease. To overcome this, we propose to benchmark a human forebrain organoid model of AD carrying amyloidogenic APPNL-G-Fmutations in co-culture with isogenic microglia immune cells. These organoids produce neurotoxic amyloid beta (A尾), a hallmark of AD, and unlike AppNL-G-F mice they also produce hyperphosphorylated Tau protein, a second hallmark of AD. We will use a transcriptomic approach to ask: 1) are these organoids in any way superior to correspondingAppNL-G-F mice? 2): how well do they overlap with human AD pathology? And 3) are they functional in response to the amyloid-lowering drug Aducanumab? Answering these questions would give the first benchmarked and disease-validated AD organoid model and will be an important step towards promoting organoids鈥 wider use in AD research, thereby reducing the heavy reliance on mice while enhancing human relevance.
  • Swedish Research Council
    1 January 2024 - 31 December 2026
    APOE variant 4 is the most common genetic risk factor for late-onset Alzheimer鈥檚 disease (AD), and it is well known that women carrying APOE4 run a 4-fold higher risk of AD than male carriers. Nevertheless, the cause of this sex difference is still enigmatic. In this project, we address the hypothesis that the drop of female sex hormone estrogen and metabolic changes at menopause impact on APOE4 regulation and downstream factors, and that this contributes to sex differences in AD. Our preliminary results support this hypothesis by suggesting that the estrogen receptor beta (ER尾) to be an important link between menopause and APOE levels. Selective ER尾 activation protects against AD pathology in an AD mouse model and can regulate APOE levels in a sex-specific manner. Making use of a multidisciplinary collaboration between experts in neuroendocrinology, AD, epidemiology, biostatistics, and genetics, we will:address the relationship between age at menopause, hormone replacement therapy, APOE4 and other genetic variants, and AD diagnosis in human cohorts,validate such relationships in an AD mouse model where menopause is simulated, andin a data-driven approach identify causative molecular networks underlying these relationships using human APOE4 brain organoid models.The outcome of this project will provide new mechanistic insights into the sex differences in AD and how such knowledge can be used for preventive clinical measures, especially for APOE4-positive women.
  • Using epigenomics to identify Alzheimer鈥檚 disease risk in gender dysphoria
    Alzheimer's Association
    1 January 2024 - 31 December 2026
  • A new model to study Alzheimer鈥檚 disease in human mini-brains
    Forska Utan Djurf枚rs枚k
    1 January 2024 - 31 December 2025
  • European Commission
    1 January 2023 - 31 December 2027
  • Ultra-sensitive multiplex detection of inflammatory and pathological markers in diseases such as Alzheimer鈥檚 disease, kidney disease and Covid19
    Ingabritt och Arne Lundbergs forskningstiftelse
    1 January 2023 - 31 December 2024
  • Estrogen receptor beta in Alzheimer鈥檚 disease
    KID Funding
    1 March 2022 - 28 February 2026
  • 探花精选 Stiftelser
    探花精选 Stiftelser
    1 January 2021 - 31 December 2024
  • National Institute on Aging
    30 September 2020 - 31 May 2024
  • Organoids as preclinical model of Parkinson
    Swedish Foundation for International Cooperation in Research and Higher Education
    1 July 2019 - 30 June 2022
  • Swedish Research Council
    1 January 2018 - 31 December 2021

Employments

  • Principal Researcher, Department of Neurobiology, Care Sciences and Society, 探花精选, 2024-

Degrees and Education

  • Docent, 探花精选, 2018
  • Doctor Of Philosophy, Department of Biosciences and Nutrition, 探花精选, 2006
  • Bachelor Of Medical Science, 探花精选, 1998

Visiting research fellowships

  • Postdoc, Friedrich Miescher Institute, Postdoc, 2010-2013

News from KI

Events from KI